357 related articles for article (PubMed ID: 27081478)
1. Probiotics in critically ill children.
Singhi SC; Kumar S
F1000Res; 2016; 5():. PubMed ID: 27081478
[TBL] [Abstract][Full Text] [Related]
2. Probiotic use in the critically ill.
Singhi SC; Baranwal A
Indian J Pediatr; 2008 Jun; 75(6):621-7. PubMed ID: 18759092
[TBL] [Abstract][Full Text] [Related]
3. Probiotics for prevention of necrotizing enterocolitis in preterm infants.
AlFaleh K; Anabrees J
Evid Based Child Health; 2014 Sep; 9(3):584-671. PubMed ID: 25236307
[TBL] [Abstract][Full Text] [Related]
4. Immunology and probiotic impact of the newborn and young children intestinal microflora.
Bezirtzoglou E; Stavropoulou E
Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of efficacy of probiotics in prevention of candida colonization in a PICU-a randomized controlled trial.
Kumar S; Bansal A; Chakrabarti A; Singhi S
Crit Care Med; 2013 Feb; 41(2):565-72. PubMed ID: 23361033
[TBL] [Abstract][Full Text] [Related]
6. Cochrane in context: probiotics for prevention of necrotizing enterocolitis in preterm infants.
Robinson J
Evid Based Child Health; 2014 Sep; 9(3):672-4. PubMed ID: 25236308
[TBL] [Abstract][Full Text] [Related]
7. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial.
Jain PK; McNaught CE; Anderson AD; MacFie J; Mitchell CJ
Clin Nutr; 2004 Aug; 23(4):467-75. PubMed ID: 15297081
[TBL] [Abstract][Full Text] [Related]
8. Role of probiotics in prevention of Candida infection in critically ill children.
Kumar S; Singhi S
Mycoses; 2013 May; 56(3):204-11. PubMed ID: 23176162
[TBL] [Abstract][Full Text] [Related]
9. Controversies in the management of the critically ill: the role of probiotics.
Theodorakopoulou M; Perros E; Giamarellos-Bourboulis EJ; Dimopoulos G
Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S41-4. PubMed ID: 23664676
[TBL] [Abstract][Full Text] [Related]
10. Probiotic Bacterial Application in Pediatric Critical Illness as Coadjuvants of Therapy.
Zanza C; Romenskaya T; Longhitano Y; Piccolella F; Racca F; Tassi MF; Rubulotta F; Abenavoli L; Shiffer D; Franceschi F; Migneco A; Saviano A; Piccioni A; Ojetti V
Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440989
[TBL] [Abstract][Full Text] [Related]
11. Probiotics, prebiotics, and synbiotics.
de Vrese M; Schrezenmeir J
Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
[TBL] [Abstract][Full Text] [Related]
12. Probiotic, prebiotic, and synbiotic use in critically ill patients.
Morrow LE; Gogineni V; Malesker MA
Curr Opin Crit Care; 2012 Apr; 18(2):186-91. PubMed ID: 22343306
[TBL] [Abstract][Full Text] [Related]
13. Probiotics in critically ill patients.
Madsen K
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S116-8. PubMed ID: 18806700
[TBL] [Abstract][Full Text] [Related]
14. Probiotics for prevention and treatment of diarrhea.
Guandalini S
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S149-53. PubMed ID: 21992955
[TBL] [Abstract][Full Text] [Related]
15. Probiotic use and prevalence of candidemia and candiduria in a PICU.
Kumar S; Singhi S; Chakrabarti A; Bansal A; Jayashree M
Pediatr Crit Care Med; 2013 Nov; 14(9):e409-15. PubMed ID: 23965638
[TBL] [Abstract][Full Text] [Related]
16. Probiotics and prebiotics: role in prevention of nosocomial sepsis in preterm infants.
Nair V; Soraisham AS
Int J Pediatr; 2013; 2013():874726. PubMed ID: 23401695
[TBL] [Abstract][Full Text] [Related]
17. Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report.
Isolauri E; Salminen S;
J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S91-6. PubMed ID: 18542035
[TBL] [Abstract][Full Text] [Related]
18. Probiotics in the intensive care unit.
Morrow LE; Gogineni V; Malesker MA
Nutr Clin Pract; 2012 Apr; 27(2):235-41. PubMed ID: 22473797
[TBL] [Abstract][Full Text] [Related]
19. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study.
Manzoni P; Mostert M; Leonessa ML; Priolo C; Farina D; Monetti C; Latino MA; Gomirato G
Clin Infect Dis; 2006 Jun; 42(12):1735-42. PubMed ID: 16705580
[TBL] [Abstract][Full Text] [Related]
20. Use of Lactobacillus casei subspecies Rhamnosus GG and gastrointestinal colonization by Candida species in preterm neonates.
Manzoni P
J Pediatr Gastroenterol Nutr; 2007 Dec; 45 Suppl 3():S190-4. PubMed ID: 18185091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
